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Passage of human hepatitis A virus (HAV) in cell culture results in attenuation of the virus as well as
progressive increases in the efficiency of virus replication in cell culture. Because the presence of identical
mutations within the 5' nontranslated regions (5'NTRs) of several independently isolated cell culture-adapted
HAV variants suggests that the 5'NTR may play a role in determining this change in virus host range, we
constructed chimeric infectious cDNA clones in which portions of the 5'NTR of cell culture-adapted
HM175/p35 virus were replaced with cDNA from either wild-type virus (HM175/wt) or a second independently
isolated, but closely related cell culture-adapted virus (HM175/pl6). Substitution of the complete 5'NTR of
HM175/p35 with the 5'NTR of HM175/wt resulted in virus with very small replication foci in continuous
African green monkey kidney (BS-C-1) cells, indicating that 5'NTR mutations in HM175/p35 virus are
required for optimal growth in these cells. A chimera with the 5'NTR sequence of HM175/p16 retained the
large foci of HM175/p35 virus, while the growth properties of other viruses having chimeric 5'NTR sequences
indicated that mutations at bases 152 and/or 203 to 207 enhance replication in BS-C-1 cells. These findings were
confirmed in one-step growth experiments, which also indicated that radioimmunofocus size is a valid measure
of virus replication competence in cell culture. An additional mutation at base 687 of HM175/pl6 had only a
minor role in enhancing growth. In contrast to their effect in BS-C-1 cells, these 5'NTR mutations did not
enhance replication in continuous fetal rhesus monkey kidney (FRhK4) cells. Thus, mutations at bases 152
and/or 203 to 207 enhance the replication of HAV in a highly host cell-specific fashion.
Hepatitis A virus (HAV), now classified within the genus
Hepatovirus of the family Picornaviridae, is a hepatotropic
virus which commonly causes acute viral hepatitis in hu-
mans (13). Considerable efforts have been expended on the
development of HAV vaccines since the first demonstration
that the virus may be propagated in cultures of primate cells.
Good progress has been made in the development of forma-
lin-inactivated whole-virus vaccines, but progress has been
much slower with attenuated-vaccine candidates, which
offer substantial theoretical advantages over inactivated
products in terms of cost, ease of administration, and
perhaps duration of immunity (21). It has been shown that
the adaptation of wild-type HAV to growth in cell culture
and subsequent successive passaging of virus result in a
marked reduction in the ability of the virus to cause acute
hepatocellular disease in experimentally challenged primates
(18). However, this attenuation of the hepatovirulence of
HAV is accompanied by an apparent reduction in the
replication competence of the virus in vivo, with the result
that infection with cell culture-adapted, attenuated variants
leads to only low-level antibody responses (17).
Because new approaches may be required for the devel-
opment of better attenuated-vaccine candidates, we have
been interested in the molecular mechanisms underlying the
phenotypic changes which accompany the adaptation and
passage of HAV in cell culture. In a previous study, we
found that the particle/infectivity ratio of a cell culture-
adapted HAV variant (HM175/pl6 virus) was approximately
4,000-fold lower than that of its wild-type parent (HM175/wt
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virus), when the abilities of both viruses to form visible
replication foci were studied over a period of 14 days in
continuous cultures of African green monkey kidney (BS-
C-1) cells (12). HM175/pl6 virus contains only 19 mutations
from the HM175/wt sequence throughout its 7.5-kb genome.
Seven of these mutations are either identical with or very
similar to mutations present in another independently iso-
lated cell culture-adapted variant of the HM175 strain of
HAV (HM175/p35 virus), suggesting that these mutations
might be particularly important in adaptation (12). An anal-
ysis of chimeric infectious cDNAs with contributions from
HM175/p35 virus and its wild-type parent (HM175/wt) has
indicated that mutations within the P2 region of the genome
(putatively proteins 2B and 2C) are required for efficient
replication of HM175/p35 in cell culture (9). However, the
occurrence of identical mutations within the 5' nontranslated
regions (5'NTRs) of the HM175/pl6 and HM175/p35 viruses,
as well as in a third cell culture isolate of HM175 virus (19),
suggests that the 5'NTR may also play an important role in
determining the growth characteristics of HAV in cell cul-
ture (12). This hypothesis was recently confirmed in studies
examining the growth of HAV variants with chimeric ge-
nomes in cultured African green monkey kidney cells (6, 9).
To better define 5'NTR mutations which positively influ-
ence HAV replication in cell culture, we constructed a series
of 5'NTR chimeras within the background genome of the
infectious HM175/p35 clone. These chimeras contain cDNA
representing segments of the 5'NTRs from HM175/wt and
HM175/pl6 viruses. Analysis of the growth properties of
viruses rescued from these chimeras indicates that mutations
at bases 152 and/or 203 to 207 of the 5'NTR strongly enhance
replication competence in continuous cultures of African
green monkey kidney cells.
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MATERIALS AND METHODS
Cell culture propagation of HAV. HM175 virus variants
were grown in continuous cultures of African green monkey
kidney (BS-C-1) or fetal rhesus monkey kidney (FRhK-4)
cells maintained in Eagle's minimal essential medium with
Earle's salts, 100 mM glutamine, and penicillin and strepto-
mycin (MEM) supplemented with 2% fetal bovine serum.
BS-C-1 cells were obtained from L. Binn of the Walter Reed
Army Institute of Research, Washington, D.C., and used at
passages 70 to 101. FRhK-4 cells were obtained from M.
Sobsey, The University of North Carolina at Chapel Hill,
and were utilized at passage 92.
HM175/p16 virus is a plaque-purified virus which was
isolated from the liver of an experimentally infected marmo-
set (passage 6 of the wild-type human virus in marmosets
and which has been passaged 16 times in low-passage or
continuous cultures of African green monkey kidney cells
(12). This virus has recently been shown to be substantially
attenuated in primates (15). HM175/p35 virus was indepen-
dently isolated from human feces and subsequently passaged
35 times in low-passage African green monkey kidney cells;
this virus has been clonally isolated by limiting dilution
passage, and it is attenuated in primates (4). The HM175/p35
virus employed in these studies was rescued from the
infectious molecular clone, pG3HAV/7 (see below). Al-
though independently adapted to cell culture, HM175/p16
and HM175/p35 viruses contain a number of identical muta-
tions from the presumptive wild-type virus sequence, includ-
ing mutations at bases 152 and 203 to 207 within the 5'NTR
(Table 1) (12).
HAV cDNA clones. Plasmid stocks were purified from
Escherichia coli TG1 transformed with cDNA constructs.
The infectious genome-length cDNA of pHAV/7 (represent-
ing the genome of HM175/p35 virus) (5) was removed from
the plasmid by partial HindIII and XbaI digestion and
inserted into the multiple cloning site of transcriptional
vector pGEM3 (Promega) downstream of the SP6 promoter
to create pG3HAV/7. Chimeric genome-length cDNA clones
were constructed from pG3HAV/7 by replacing restriction
fragments representing segments of the 5'NTR of HM175/
p35 virus with cDNA segments derived from HM175/wt (23)
or HM175/p16 virus (12) (Fig. 1). cDNA representing the
5'NTR sequence of HM175/p16 virus was derived from the
pS'pl6 plasmid. This plasmid was constructed by amplifica-
tion of an 895-bp fragment from the pHAVCHll9 plasmid
(12) by polymerase chain reaction using primers A+xO
(5'-tcactcaagcTTTCAAGAAGGGTCTCCGG-3'), which
corresponds to the 5' 19 bases of HM175/p16 virus preceded
by an upstream HindIII site, and A-870 (5'-ATTGATCCA
CAGAACT), complementary to bases 870 to 885. The poly-
merase chain reaction product was restricted with HindIII
and XbaI and inserted into the multiple cloning site of
pGEM3 downstream of the SP6 RNA polymerase promoter
to create pS'pl6. Chimeric genome-length cDNAs were
constructed by ligation of appropriate restriction digestion
fragments from pG3HAV/7 and p5'pl6 as depicted in Fig. 1.
An additional chimera was constructed in which the 5'NTR
of HM175/p35 virus was replaced with cDNA from
pHAVLB1l3, which was derived from HM175/wt virus (23).
The 5'NTR chimeras thus contained HM175/p16 cDNA from
base positions 0 to 744 (pA/7-5'p16), 0 to 532 (pA/7-5'pl6[0-
532]), and 25 to 532 (pA/7-5'p16[25-532]) or contained wild-
type HM175 cDNA from bases 25 to 532 (pA/7-5'wt) (Fig. 1).
(Base 0 in HM175/p16 virus is an additional U residue at the
5' terminus of the genome [12].) Each construct retained the
HAV polyprotein-coding region and 3' nontranslated region
of pG3HAV/7 (HM175/p35 virus), including those mutations
within the P2 region which Emerson et al. (9) have shown to
be important for growth in cell culture. To confirm the
correctness of the constructions, the chimeric cDNAs were
sequenced through ligation sites by the dideoxynucleotide
sequencing method of Sanger et al. (20), modified for double-
stranded DNA.
In vitro transcription. Plasmid DNA (5 ,ug) was linearized
with HaeII and the 3' overhang was filled in with Klenow
fragment (5). The cDNA was extracted with phenol-chloro-
form, precipitated in ethanol, resuspended in nuclease-free
water, and transcribed with SP6 RNA polymerase (Promega)
according to the manufacturer's instructions. The cDNA
template was removed by digestion of the transcription
reaction mixture with RNase-free DNase (Promega), fol-
lowed by phenol-chloroform extraction and ethanol precip-
itation. The RNA pellet was resuspended in 60 RI of nu-
clease-free water, and the quality of the transcription
products was determined by electrophoresis in formalde-
hyde-agarose gels.
Transfection assays. Transfections were performed in 60-
mm-diameter cell culture dishes containing BS-C-1 cell
monolayers that were approximately 85% confluent. Mono-
layers were washed three times with OPTI-MEM (GIBCO
BRL) and then 3 ml of OPTI-MEM was added. A total of 50
,ul of Lipofectin (GIBCO BRL) was added to 50 ,u of RNA
(approximately 5 jig of RNA), and this mixture was slowly
added to the medium covering the cell monolayers. The cells
were incubated overnight at 35.5°C in a 5% CO2 atmosphere.
The following day, 3 ml of MEM supplemented with 20%
fetal bovine serum was added to each dish and the cells were
incubated for an additional 24 h. The medium was then
removed and replaced with MEM containing 2% fetal bovine
serum. The cultures were incubated for 2 weeks at 35.5°C in
a 5% CO2 atmosphere, at which time supernatant fluids were
removed and stored at -70°C for subsequent studies. To
assess virus growth, the cells were fixed with acetone and
stained with radiolabelled anti-HAV immunoglobulin G
(IgG) as described previously (14).
Analysis of virus replication efficiency. The efficiency with
which rescued viruses replicated in BS-C-1 or FRhK-4 cells
was assessed in radioimmunofocus assays (14). Both the size
of replication foci and the intensity of staining of individual
radioimmunofoci with 125I-labelled anti-HAV antibodies
were evaluated as measures of virus replication. Briefly,
rescued viruses were inoculated onto nearly confluent BS-
C-1 cell monolayers in 60-mm-diameter cell culture dishes.
After virus adsorption for 1 h, cell cultures were overlaid
with agarose and incubated for 2 weeks, as described previ-
ously (14). Foci of virus replication were visualized by
autoradiography after acetone fixation and staining of the
cell sheets with radioiodinated anti-HAV IgG. The diameters
of 30 representative replication foci were measured for each
virus studied, and the mean areas were determined. Plastic
discs representing the same foci were cut from the culture
dish bottoms with a cork borer, and the quantity of radiola-
belled anti-HAV IgG bound by each viral replication focus
was determined by counting in a gamma counter. As none of
the viruses studied were cytopathic, the relationship be-
tween focus size (specifically, area, which is proportionate
to the number of cells within a focus) and the individual
focus counts per minute provided an estimate of the average
amount of viral antigen produced by individual cells within
the replication focus. As an alternative measure of replica-
tion efficiency, the quantity of 125I labelled anti-HAV anti-
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FIG. 1. 5'NTRs of plasmids containing infectious genome-length HAV cDNAs utilized for transfection of BS-C-1 cells. The NTR
comprises the first 735 nucleotides of the genome. Black genome segments represent sequence derived from pG3HAV/7 (HM175/p35 virus),
while stippled segments are derived from p5'/pl6 (HM175/p16 virus) and the white segment is derived from pHAVLB113 (HM175/wt virus).
Arrowheads indicate mutations from the sequence of HM175/wt. Restriction sites used for construction of these plasmids are indicated.
bodies bound by entire cell culture dishes was determined by
direct counting and related to the input viral titer measured
in radioimmunofocus-forming units (14).
One-step HAV growth curves. The replication efficiency of
selected viruses was assessed under approximate one-step
growth conditions. BS-C-1 cells were grown until nearly
confluent in 24-well plates and inoculated with 0.1 ml ofvirus
representing a multiplicity of infection of approximately 2.0.
Following a 1-h period of adsorption, cells were washed
twice and 2.0 ml of maintenance medium was added to each
well. The cells from individual wells were harvested and
assayed for intracellular virus at 8, 24, 48, 72, and 144 h as
follows. The medium was aspirated from each well, and the
cell sheets were washed twice with Hanks' balanced salt
solution. Cells were lysed by the addition of 1 ml of MEM
containing 0.1% sodium dodecyl sulfate, and virus present in
the lysate was quantified by radioimmunofocus assay (14
days of virus growth in BS-C-1 cells) (14).
RESULTS
Viruses with different 5'NTR sequences generate radioimmu-
nofoci with different sizes in BS-C-1 cell cultures. Four chi-
meric genome-length cDNA constructs were created by re-
placing regions of the 5'NTR of HM175/p35 virus with cDNA
derived from either HM175/wt or HM175/p16 virus, as shown
in Fig. 1. In each case, the remainder of the genome down-
stream of the 5'NTR was derived from HM175/p35 virus
(pG3HAV/7). pA/7-5'pl6 contained the entire 5'NTR se-
quence of HM175/pl6, while pA/7-5'p16[0-532] and pA/7-
5'pl6[25-532] contained HM175/p16 sequence between bases
0 to 532 and 25 to 532, respectively. Within the 5'NTR,
HM175/p35 virus contains mutations from the wild-type se-
quence only within the sequence flanked by bases 123 and 208
(Table 1). Thus, pA/7-5'wt, created by splicing cDNA from
pHAVB113 and pG3HAV/7 at BspMII (base 24) and NsiI
(base 532) sites contained the entire 5'NTR sequence of
HM175/wt. The pA/7-5'pl6[25-532J, pA/7-5'pl6[0-532], pA/7-
5'pl6, and pG3HAV/7 constructs contained 3, 5, 6, and 7
single base changes from the wild-type 5'NTR sequence of
pA/7-5'wt, in each case including common mutations at base
152 (A-to-G substitution) and at least one U deletion within a
short oligo(U) tract at bases 203 to 207 (Table 1).
Runoff RNAs transcribed under direction of SP6 polymer-
ase from plasmids linearized with HaeII were predominantly
genome length (approximately 7.5 kb) (data not shown).
However, we also observed two minor subgenomic species
of approximately 4.6 and 1.6 kb, confirming previous obser-
vations (5). Virus was rescued by transfection of BS-C-1
cells with the RNA transcripts, using a liposome-mediated
transfection procedure. The replication foci generated by
these viruses in BS-C-1 cells ranged from large (similar to
that obtained with HM175/pl6 virus [12]) to very small (Fig.
2). Replacement of the 5'NTR sequence of HM175/p35 virus
(pG3HAV/7) with the corresponding sequence of wild-type
HM175 (pA/7-5'wt) resulted in virus with very small foci
(diameter of c1 mm) resembling radioimmunofoci obtained
after 2 weeks of growth of HM175/wt in BS-C-1 cells (12).
Similar replication foci were obtained with viruses rescued
from multiple identical cDNA constructs, arguing against the
chance acquisition of a mutation that was detrimental to
replication elsewhere in the genome. This result indicates
that mutations within the 5'NTR of HM175/p35 virus are
necessary for optimal growth in BS-C-1 cells.
Substitution of the complete 5'NTR of HM175/p35 with
the 5'NTR of HM175/pl6 (pA/7-5'pl6 construct) resulted in
virus with a focus size comparable to that of HM175/p35
(diameter, >3 mm) (Fig. 2) or HM175/p16 virus (data not
shown). The fact that the 5'NTRs of HM175/p35 and
HM175/p16 could substitute for each other without signifi-
TABLE 1. Phenotypes and 5'NTR mutations of HM175
virus variants
Ceul Hepatitis in NTR mutation at base(s):
Virus culture . ^ategrowtha pimates 8 124 131-134 152 203-207 687
HM175/wt + ++++ G U UUUG A IU U
HM175/p16 +++ + U A U UUUG G ddC G
HM175/p35 +++ + G C dddd G dU U
a +, very slow growth and low yields; ++ +, moderately rapid growth and
yields.
I +, inconsistent, low-level serum enzyme elevations; ++++, consistent,
marked serum enzyme elevations.
c d, deletion.
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FIG. 2. Autoradiograms of radioimmunofocus assays (BS-C-1
cells) of viruses rescued from plasmids depicted in Fig. 1. The assay
was completed 2 weeks after inoculation of the cells and represents
cell culture passage 2 of the rescued virus.
cant reduction in the growth characteristics of the virus
suggested that the mutations which these viruses share in
common within this region (at bases 152 and 203 to 207
[Table 1]) may be particularly important to the ability of
HAV to replicate efficiently in BS-C-1 cells. This hypothesis
was tested by the construction of additional plasmids in
which HM175/p16 mutations at base 687 (pA/7-5'pl6[0-532])
or bases 0, 8, and 687 (pA/7-5'pl6[25-532]) were excluded
(Fig. 1). In multiple radioimmunofocus assays in BS-C-1
cells, viruses rescued from these constructs generated sub-
stantially larger replication foci than virus with the 5'NTR
sequence of HM175/wt virus (Fig. 2). These results confirm
that it is the 5'NTR mutations at bases 152 and/or 203 to 207
that are necessary for efficient replication. Although we
noted variability in different radioimmunofocus assays, the
replication foci produced by these viruses were often smaller
(diameter of 1 to 3 mm) than those produced by HM175/p35
or A/7-5'pl6 virus (Fig. 2). These results suggest that the
mutation at 687 has a minor role in further enhancing virus
replication in BS-C-1 cells (6).
Expression of HAV antigen in vivo by viruses with different
5'NTR sequences. Considerable attention has been focused
recently on the role of the 5'NTR in controlling translation of
the proteins of picornaviruses, including HAV (1, 10). In an
attempt to examine the influence of 5'NTR mutations on
viral translation in vivo, we measured the quantity of radio-
labelled anti-HAV IgG bound to individual replication foci
produced in BS-C-1 cells by viruses rescued from the
constructs shown in Fig. 1. This measure provides an
estimate of the amount of HAV antigen produced within
each individual focus, while the size (area) of the focus is
proportionate to the number of cells infected within the
focus. As shown in Fig. 3, when we analyzed 30 repre-
sentative radioimmunofoci produced by each virus, we
found a roughly linear correlation between the mean area of
replication foci and the mean quantity of 125I-labelled anti-
HAV antibodies bound by each focus. Thus, the amount of
viral antigen produced within individual cells was not mea-
surably different with any of the viruses studied, while the
viruses with greater replication efficiency spread to a larger
number of cells within individual replication foci over the
2-week period of incubation. However, it is important to
point out that we do not know the linearity of the relation-
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FIG. 3. Viral antigen content versus size (area) of individual
radioimmunofoci produced by 5'NTR chimeric viruses in BS-C-1
cells. Symbols: A, HM175/p35; 0, A/7-5'pl6; *, A/7-5'pl6[0-532];
M, A/7-5'pl6[25-532]; A, A/7-5'wt. Each point represents the mean
values of 30 representative replication foci, while lines with arrow-
heads in both dimensions indicate standard deviations.
assays and the intracellular viral antigen content. It may be
that 1"I-labelled anti-HAV antibody staining saturates at
relatively low intracellular antigen concentrations.
One-step growth analysis of 5'NTR mutant viruses. Be-
cause the radioimmunofocus assay measures the spread of
HAV antigen from an infectious focus within a cell sheet,
determination of focus size in this assay should be a good
measure of the adaptation of virus to growth in cell culture.
To validate this hypothesis, we assessed the replication of
three of the rescued viruses in BS-C-1 cells under one-step
growth conditions (Fig. 4). To generate sufficient virus for
these assays, it was necessary to pass each virus once in cell
culture after its rescue from cDNA. Thus, these one-step
growth experiments represented passage 3 of these viruses
in cell culture after rescue, while the radioimmunofocus
assays for quantitation of the one-step growth harvests
represented passage 4 in cell culture after virus rescue.
These one-step growth experiments confirmed the earlier
results and also demonstrated that radioimmunofocus size is
a valid measure of cell culture adaptation. The replication of
A/7-5'wt virus (Fig. 4B) was significantly slower than that of
A/7-5'pl6[25-532] virus (Fig. 4A). Although the infectious
titers of A/7-5'pl6[25-532] and A/7-5'wt were nearly identical
at 8 h, the A/7-5'wt yields were significantly lower at 24 and
48 h and approximately 10-fold less at 72 h. Intracellular
A/7-5'pl6[25-532] virus plateaued at 72 h, so that the titers of
these viruses were approximately the same at 144 h. While
the infectious titers of HM175/p35 virus (Fig. 4C) were less
at 8 and 24 h, the replication kinetics of this virus indicated
somewhat more rapid growth than for the A/7-5'pl6[25-532]
virus. The differences in the replication rates of these viruses
thus reflect the different radioimmunofocus sizes generated
by these viruses (Fig. 2). The results of the one-step growth
analysis, therefore, confirm that the mutations at bases 152
and/or 203 to 207 enhance the growth of HAV in BS-C-1
cells.
Replication competence of5'NTR chimeras in FRhK-4 cells.
To determine whether the differences in the replication
competence of viruses which we observed in BS-C-1 cells
were also present in a different cell type, we compared
J. VIROL.
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FIG. 4. Intracellular virus accumulation measured under approximate one-step growth conditions in BS-C-1 cells infected with virus
rescued from pA/7-5'pl6[25-532] (A), pA/7-5'wt (B), and pG3HAV/7 (C). RFU, radioimmunofocus-forming units.
radioimmunofocus size and viral antigen production in BS-
C-1 cells and continuous cultures of fetal rhesus monkey
kidney (FRhK-4) cells. Although both HM175 strain variants
we studied were adapted to growth in African green monkey
kidney cells, FRhK-4 cells have been used widely for
propagation ofHAV in cell culture and in a previous study of
mutations responsible for the cell culture adaptation pheno-
type of HM175 virus (9). Parallel cultures of FRhK-4 and
BS-C-1 cells were inoculated with increasing quantities of
viruses rescued from the constructs shown in Fig. 1, as well
as HM175/pl6 virus. Cells were maintained under agarose
overlays for 2 weeks, then fixed, and stained with radiola-
belled anti-HAV antibodies. We found less than a 3.3-fold
difference in the infectious titers of each of the rescued
viruses when these were determined by independent radio-
immunofocus assays carried out in BS-C-1 and FRhK-4 cells
(data not shown). However, there were dramatic differences
in the size of replication foci in these cell lines (Fig. 5).
Differences in the sizes of replication foci of the HM175/p35,
A/7-5'pl6, and A/7-5'wt viruses were again noted in BS-C-1
cells. The replication foci obtained with each of the rescued
viruses were smaller in FRhK-4 cells than in BS-C-1 cells.
Moreover, there were no apparent differences in the size of
replication foci obtained with viruses having wild-type or
mutant 5'NTR sequences in FRhK-4 cells (Fig. 5), indicating
that the 5'NTR mutations present in HM175/p35 and
HM175/pl6 viruses do not enhance growth in this cell line.
In both BS-C-1 and FRhK-4 cells, individual replication foci
were occasionally significantly larger than others, suggesting
the possibility that new mutations were accumulating with
continued passage of rescued viruses in cell cultures. This
experiment represented passage 3 of the rescued viruses in
cell culture. A similar phenomenon was noted in the one-
step growth experiments described above (data not shown).
We also measured viral antigen accumulation in the in-
fected BS-C-1 and FRhK-4 cell cultures maintained under
agarose overlays (Fig. 6). These results, which were not
obtained under one-step growth conditions, indicated an
approximately 10-fold reduction in the expression of antigen
by BS-C-1 cell cultures infected with virus containing the
wild-type 5'NTR sequence compared with cell cultures
infected with an equivalent quantity of virus containing the
5'NTR sequence of either HM175/p35 or HM175/pl6 virus
(Fig. 6A). In contrast, the antigen content of infected
FRhK-4 cells was much less than that of BS-C-1 cells
infected in parallel with the same inocula, and little differ-
ence was evident in antigen expression by FRhK-4 cells
infected with viruses having different 5'NTR sequences (Fig.
6B).
DISCUSSION
Previous studies have indicated that mutations responsible
for the adaptation of HAV to growth in cell culture are











FIG. 5. Radioimmunofoci generated by virus rescued from
pG3HAV/7 (HM175/p35), pA/7-5'pl6, and pA/7-5'wt in continuous
cultures of African green monkey (BS-C-1) (a) and fetal rhesus
monkey kidney (FRhK-4) (b) cells.
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FIG. 6. Accumulation of HAV antigen in BS-C-1 (A) and FRhK-4 (B) cells infected with viruses rescued from cDNA constructs depicted
in Fig. 1. Symbols are as described in the legend to Fig. 3, 0 = HM175/pl6 virus, which differs from the other viruses with respect to
mutations outside of the 5'NTR (11). Cells were maintained beneath agarose overlays for 14 days after infection, then fixed, and stained with
"MI-labelled anti-HAV antibodies. The counts per minute (cpm) bound by each culture dish is shown as a function of inoculum size
(radioimmunofocus-forming units [RFU] measured in BS-C-1 cells). Background binding of "MI-labelled anti-HAV antibodies ranged from
1,939 to 3,376 cpm.
tive 2B and 2C proteins (8, 9). In this report, however, we
present data which demonstrate that mutations within a
small region of the 5'NTR of the HAV genome also substan-
tially enhance the replication of HM175 variants in continu-
ous cultures of African green monkey kidney (BS-C-1) cells.
Mutations which enhance viral replication in BS-C-1 cells
include an A-to-G substitution at base 152 and/or the dele-
tion of one or two U residues within a short oligo(U) tract at
bases 203 to 207. Both mutations are present in the cell
culture-adapted HM175/p16 and HM175/p35 viruses. In ad-
dition, there is also a U deletion at bases 203 to 207 in
HM175/p59 virus, a third HM175 variant which was inde-
pendently adapted to growth and serially passaged in African
green monkey kidney cells (19). Thus, it may be this muta-
tion which is the most important in enhancing growth in
BS-C-1 cells. A third mutation, a U-to-G substitution at base
687, plays a definite but less important role in enhancing
replication in BS-C-1 cells (6) and is found in both HM175/
p16 and HM175/p59 viruses. All of the infectious constructs
which we examined contained the 2B and 2C mutations of
HM175/p35 which have been shown to be important for
replication in cell culture.
Compared with earlier studies examining the effects of
mutations on growth of HAV in cell cultures (8, 9), our
findings are enhanced by our use of more-quantitative mea-
sures of virus replication. We compared the replication rates
of viruses having different mutations under one-step growth
conditions (Fig. 4). Such an approach is difficult to apply to
large numbers of viruses, however, because of the slow and
generally noncytolytic growth of HAV. However, quantita-
tive measurements of radioimmunofocus size and antigen
content (Fig. 3) correlate with differences in replication
kinetics under one-step conditions and provide a simple and
direct measure of replication competence.
The exact mechanism by which these 5'NTR mutations
affect viral replication in certain cell cultures and hence the
host range of the virus is not understood. However, the
5'NTRs of other picornaviruses have been shown to initiate
viral translation by an unusual process of internal ribosomal
entry, an event occurring many hundreds of bases down-
stream of the uncapped 5' terminus of the RNA (10). Recent
work has confirmed the existence of a similar internal
ribosomal entry site (IRES) within the 5'NTR of HAV (2).
Comparison of a model of the secondary structure of the
HAV 5'NTR with the structure proposed for the 5'NTR of
encephalomyocarditis virus and analysis of in vitro transla-
tion experiments using 5' truncated HAV RNAs have sug-
gested that the 5' terminus of the HAV IRES is located
upstream of base 355 (1). This has been confirmed in a more
recent study examining translation in rabbit reticulocyte
lysates programmed with bicistronic constructs in which the
HAV 5'NTR controls translation of the downstream reporter
gene (2). Thus, available data suggest that the locations of
the 5'NTR mutations which we have shown to positively
influence the replication of HAV in BS-C-1 cells lie within
the HAV IRES element or very close to its 5' limit. Modeling
studies suggest that nucleotides 203 to 207 are located near
the base of a conserved stem-loop structure and that U
deletions at bases 203 to 207 reduce the size of a small bubble
within this structure (1) (Fig. 7). Base 152 is located near the
3' terminus of a putatively single-stranded pyrimidine-rich
tract. Deletion of sequence downstream of base 151 signifi-
cantly impairs HAV IRES-directed translation in vitro (2).
While a primary effect on RNA replication cannot be
excluded, the locations of these mutations thus suggest the
possibility that they act to enhance replication by positively
influencing translation of the HAV polyprotein. We found no
measurable increase in the binding of radiolabelled antibody
to cells infected with chimeric viruses containing wild-type
or cell culture-adapted 5'NTR sequences (Fig. 3), but the
ability of this in vivo assay to distinguish different levels of
intracellular antigen accumulation remains unproven. In
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FIG. 7. Proposed secondary structure of part of domain III of the
HM175/wt 5'NTR (1). The arrow indicates the location of mutations
(U deletions) at base positions 203 to 207 which are present in
HM175/p16 virus.
addition, it may be that the spread of virus to adjacent cells
occurs only after a certain level of viral replication (intrac-
ellular antigen accumulation) is reached. In fact, data from
the one-step growth experiments suggest that viruses with
and without these mutations eventually reach the same
intracellular titers (compare Fig. 4A and B) but that virus
lacking the mutations takes longer to do so. Examination of
the translational efficiencies of RNAs transcribed from the
chimeric 5'NTR constructs in rabbit reticulocyte lysates has
failed to reveal any enhancement that could be attributed to
specific mutations (2). However, these data do not exclude a
role for these mutations in enhancing translation of HAV
RNA in vivo. We found the positive influence of these
mutations on virus replication to be present in BS-C-1 cells,
which are derived from African green monkeys, but not in
FRhK-4 cells which are derived from the kidneys of fetal
rhesus monkeys. The 5'NTR mutations thus act in a highly
host cell-specific fashion, as suggested by Emerson and
coworkers (9), and an effect on translation would not be
expected in reticulocyte lysates.
As both HM175/p16 and HM175/p35 virus were adapted to
growth in cultures of African green monkey kidney cells, it is
not surprising that a very host cell-specific effect might be
seen only in closely related cells. The 5'NTRs of the
picornaviruses bind several host cell proteins which are
likely to play roles in virus translation and/or viral RNA
replication (7, 11, 16). Recent evidence from our laboratory
suggests that the 5'NTR of HAV similarly binds several
BS-C-1 cell proteins (3). The 5'NTR mutations which we
have shown to positively influence the replication of the
virus in these cells may thus act by enhancing or reducing
the affinity of the 5'NTR for these cellular RNA-binding
proteins. Further investigation of this hypothesis is likely to
provide additional information on the mechanisms by which
these mutations enhance replication of HAV in cell culture
and in a larger sense may provide insights into the mecha-
nisms of attenuation mediated by 5'NTR mutations in other
picomaviruses such as poliovirus (22).
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